203 related articles for article (PubMed ID: 22469709)
1. Pancreatic resection for metastases from renal cancer: long term outcome after surgery and immunotherapy approach - single center experience.
Gardini A; Morgagni P; Milandri C; Riccobon A; Ridolfi R; La Barba G; Saragoni L; Amadori D; Garcea D
Hepatogastroenterology; 2012 May; 59(115):687-90. PubMed ID: 22469709
[TBL] [Abstract][Full Text] [Related]
2. The place of enucleation and enucleo-resection in the treatment of pancreatic metastasis of renal cell carcinoma.
Yazbek T; Gayet B
JOP; 2012 Jul; 13(4):433-8. PubMed ID: 22797401
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic metastasis of renal cell carcinoma: presentation, treatment and survival.
Faure JP; Tuech JJ; Richer JP; Pessaux P; Arnaud JP; Carretier M
J Urol; 2001 Jan; 165(1):20-2. PubMed ID: 11125354
[TBL] [Abstract][Full Text] [Related]
4. Survival data justifies resection for pancreatic metastases.
Strobel O; Hackert T; Hartwig W; Bergmann F; Hinz U; Wente MN; Fritz S; Schneider L; Büchler MW; Werner J
Ann Surg Oncol; 2009 Dec; 16(12):3340-9. PubMed ID: 19777190
[TBL] [Abstract][Full Text] [Related]
5. [Pulmonary metastases of the clear cell (conventional) renal cell carcinoma--options and results of surgical treatment].
Vodicka J; Spidlen V; Simánek V; Safránek J; Fichtl J; Mukensnabl P; Fínek J; Rousarová M
Klin Onkol; 2011; 24(4):293-7. PubMed ID: 21905621
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer.
Nakamura M; Wada J; Suzuki H; Tanaka M; Katano M; Morisaki T
Anticancer Res; 2009 Mar; 29(3):831-6. PubMed ID: 19414316
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic resection for metastatic tumors to the pancreas.
Sperti C; Pasquali C; Liessi G; Pinciroli L; Decet G; Pedrazzoli S
J Surg Oncol; 2003 Jul; 83(3):161-6; discussion 166. PubMed ID: 12827684
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological features and surgical outcome of isolated metastasis of renal cell carcinoma.
Akatsu T; Shimazu M; Aiura K; Ito Y; Shinoda M; Kawachi S; Tanabe M; Ueda M; Kitajima M; Kitagawa Y
Hepatogastroenterology; 2007 Sep; 54(78):1836-40. PubMed ID: 18019729
[TBL] [Abstract][Full Text] [Related]
9. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy.
Naitoh J; Kaplan A; Dorey F; Figlin R; Belldegrun A
J Urol; 1999 Jul; 162(1):46-50. PubMed ID: 10379737
[TBL] [Abstract][Full Text] [Related]
10. Metastatic pancreatic tumors: what is the optimal treatment?
Sperti C; Merigliano S; Moletta L
Minerva Chir; 2015 Apr; 70(2):131-9. PubMed ID: 25645113
[TBL] [Abstract][Full Text] [Related]
11. Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2-based immunotherapy.
Lee DS; White DE; Hurst R; Rosenberg SA; Yang JC
Cancer J Sci Am; 1998; 4(2):86-93. PubMed ID: 9532410
[TBL] [Abstract][Full Text] [Related]
12. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of surgical management of pulmonary metastases from renal cell carcinoma.
Marulli G; Sartori F; Bassi PF; dal Moro F; Gino Favaretto A; Rea F
Thorac Cardiovasc Surg; 2006 Dec; 54(8):544-7. PubMed ID: 17151970
[TBL] [Abstract][Full Text] [Related]
14. Value of pancreatic resection for cancer metastatic to the pancreas.
Sweeney AD; Wu MF; Hilsenbeck SG; Brunicardi FC; Fisher WE
J Surg Res; 2009 Oct; 156(2):189-98. PubMed ID: 19375718
[TBL] [Abstract][Full Text] [Related]
15. Surgery for metastasis to the pancreas: is it safe and effective?
Niess H; Conrad C; Kleespies A; Haas F; Bao Q; Jauch KW; Graeb C; Bruns CJ
J Surg Oncol; 2013 Jun; 107(8):859-64. PubMed ID: 23637007
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic resection for metastatic renal cell carcinoma: a single center experience and review of the literature.
Schauer M; Vogelsang H; Siewert JR
Anticancer Res; 2008; 28(1B):361-5. PubMed ID: 18383870
[TBL] [Abstract][Full Text] [Related]
18. No role of adjuvant systemic therapy after complete metastasectomy in metastatic renal cell carcinoma?
Kwak C; Park YH; Jeong CW; Lee SE; Ku JH
Urol Oncol; 2007; 25(4):310-6. PubMed ID: 17628297
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis.
Patel A; Soonawalla P; Shepherd SF; Dearnaley DP; Kellett MJ; Woodhouse CR
J Urol; 1996 Mar; 155(3):868-74. PubMed ID: 8583595
[TBL] [Abstract][Full Text] [Related]
20. [Local recurrence of renal cell carcinoma after nephrectomy].
Pereverzev AS; Shchukin DV; Iliukhin IuA
Urologiia; 2003; (6):14-8. PubMed ID: 14708237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
